Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04817969 · ClinicalTrials.gov registry record · NA
Persona Ti-Nidium Post-Market Clinical Follow-up
A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 7
- Study locations
NCT04817969: Active NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
NCT04817969 is a NA study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 240 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (95% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04817969, a NA study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 7
- Study locations
Study Summary
The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.
Primary Outcome
A patient reported functional outcome score for knee arthroplasty. This score ranges from 0-48, with higher scores indicating a better outcome.
Conditions Studied
Interventions
- DEVICE Zimmer Biomet Persona Ti-Nidium Total Knee System
Study Locations (7)
Colorado
- Denver Hip & Knee, Inc. - Parker
Maryland
- MedStar Health Research Institute - Hyattsville
Mississippi
- Mississippi Sports Medicine and Orthopaedic Center - Jackson
New Mexico
- New Mexico Orthopaedic Associates - Albuquerque
North Carolina
- Duke University - Durham
Pennsylvania
- Rothman Orthopaedic Institute - Philadelphia
South Dakota
- Monument Health Rapid City Hospital, Inc. - Rapid City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2034-05 |
| Phase | NA |
What the registry record for NCT04817969 still lists
NCT04817969 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (95% lower).
The record links to 10 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Zimmer Biomet Persona Ti-Nidium Total Knee System is the first listed.
NCT04817969 lists 7 locations in 7 states (Colorado, Maryland, Mississippi).
Frequently Asked Questions
What is clinical trial NCT04817969 about?
NCT04817969 is a clinical study titled "Persona Ti-Nidium Post-Market Clinical Follow-up". The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.
What is the current status of trial NCT04817969?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2021-06-01. Estimated completion is 2034-05.
What conditions does trial NCT04817969 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis, Knee Pain Chronic, Traumatic Arthritis.
What interventions are being tested in trial NCT04817969?
The interventions under investigation include: Zimmer Biomet Persona Ti-Nidium Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT04817969?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04817969 being conducted?
This trial has 7 study locations across Colorado, Maryland, Mississippi, New Mexico, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04817969's enrollment target sits among peer trials
240 76th of 197 higher than 122 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI